May 14, 2024 6:00 am EDT Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
Feb 26, 2024 4:05 pm EST Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
Feb 20, 2024 8:05 am EST Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
Feb 14, 2024 4:05 pm EST Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
Feb 13, 2024 4:05 pm EST Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones